Circulation, Vol 70, 479-484, Copyright © 1984 by American Heart Association
HD White, EM Antman, MA Glynn, JJ Collins, LH Cohn, RJ Shemin and PL Friedman
Forty-one patients undergoing coronary artery bypass grafting were randomly
assigned to receive prophylactic timolol or placebo, given in a
double-blind fashion. beta-Adrenoceptor-blocking therapy was stopped at
least one half-life before surgery. Three to 7 hr after surgery (304 +/- 56
min), 0.5 mg of timolol or placebo was given intravenously twice daily in a
double-blind manner. When oral medications were resumed postoperatively, 10
mg of timolol twice daily or placebo was continued orally. Continuous
electrocardiograms were recorded for 24 hr before and for 7 days after
surgery with a standard cassette recorder. No patient received digoxin.
Both groups were comparable for frequency of preoperative supraventricular
arrhythmias, left ventricular ejection fraction, duration of
cardiopulmonary bypass, aortic cross-clamp time, number of bypass grafts,
and total duration of monitoring. Analysis of arrhythmias was done by hand
counts, and supraventricular arrhythmias were divided into supraventricular
tachycardia and atrial fibrillation and/or flutter. Timolol decreased the
frequency of supraventricular tachycardia (581 episodes placebo vs 84
timolol; p less than .05) and of atrial fibrillation and/or flutter (291
episodes placebo vs five timolol; p less than .05). Timolol decreased the
number of patients with severe (heart rate greater than 200 beats/min,
duration greater than 50 beats) episodes of supraventricular tachycardia
(four placebo vs 0 timolol; p less than .05) and also decreased the number
of episodes of severe (heart rate greater than 200 beats/min, duration
greater than 5 min) atrial fibrillation and/or flutter (16 placebo vs one
timolol; p less than .005). There were differences in the durations of
supraventricular arrhythmias.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery
This article has been cited by other articles:
![]() |
J. Halonen, T. Hakala, T. Auvinen, J. Karjalainen, A. Turpeinen, A. Uusaro, P. Halonen, J. Hartikainen, and M. Hippelainen Intravenous Administration of Metoprolol Is More Effective Than Oral Administration in the Prevention of Atrial Fibrillation After Cardiac Surgery Circulation, July 4, 2006; 114(1_suppl): I-1 - I-4. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Edgerton, M. A. Herbert, S. L. Prince, J. L. Horswell, L. Michelson, M. J. Magee, T. M. Dewey, Z. J. Edgerton, and M. J. Mack Reduced Atrial Fibrillation in Patients Immediately Extubated After Off-Pump Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 2006; 81(6): 2121 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 39S - 47S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. DiDomenico and M. G. Massad Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery Ann. Thorac. Surg., February 1, 2005; 79(2): 728 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gaudino, F. Andreotti, R. Zamparelli, A. Di Castelnuovo, G. Nasso, F. Burzotta, L. Iacoviello, M. B. Donati, R. Schiavello, A. Maseri, et al. The -174G/C Interleukin-6 Polymorphism Influences Postoperative Interleukin-6 Levels and Postoperative Atrial Fibrillation. Is Atrial Fibrillation an Inflammatory Complication? Circulation, September 9, 2003; 108(90101): II-195 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D Taylor, J G Groen, S L Thorn, C T Lewis, and A J Marshall New insights into onset mechanisms of atrial fibrillation and flutter after coronary artery bypass graft surgery Heart, December 1, 2002; 88(5): 499 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Crystal, S. J. Connolly, K. Sleik, T. J. Ginger, and S. Yusuf Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery: A Meta-Analysis Circulation, July 2, 2002; 106(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tokmakoglu, O. Kandemir, S. Gunaydin, Z. Catav, C. Yorgancioglu, and Y. Zorlutuna Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 401 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Maisel, J. D. Rawn, and W. G. Stevenson Atrial Fibrillation after Cardiac Surgery Ann Intern Med, December 18, 2001; 135(12): 1061 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stamou, P. C. Hill, G. A. Sample, E. Snider, A. J. Pfister, R. C. Lowery, and P. J. Corso Prevention of Atrial Fibrillation After Cardiac Surgery : The Significance of Postoperative Oral Amiodarone Chest, December 1, 2001; 120(6): 1936 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. d'Amato, E. B. Savage, R. J. Wiechmann, T. Sakert, D. H. Benckart, and J. A. Magovern Reduced incidence of atrial fibrillation with minimally invasive direct coronary artery bypass Ann. Thorac. Surg., December 1, 2000; 70(6): 2013 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ascione, M. Caputo, G. Calori, C. T. Lloyd, M. J. Underwood, and G. D. Angelini Predictors of Atrial Fibrillation After Conventional and Beating Heart Coronary Surgery : A Prospective, Randomized Study Circulation, September 26, 2000; 102(13): 1530 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Daoud, R. Dabir, M. Archambeau, F. Morady, and S. A. Strickberger Randomized, Double-Blind Trial of Simultaneous Right and Left Atrial Epicardial Pacing for Prevention of Post-Open Heart Surgery Atrial Fibrillation Circulation, August 15, 2000; 102(7): 761 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Evrard, M. Gonzalez, J. Jamart, B. Malhomme, D. Blommaert, P. Eucher, and E. Installe Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol Ann. Thorac. Surg., July 1, 2000; 70(1): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Lee, C.-M. Chang, M.-J. Lu, R.-J. Lee, J.-J. Cheng, C.-R. Hung, and S.-A. Chen Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting Ann. Thorac. Surg., July 1, 2000; 70(1): 157 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dorge, F. A. Schoendube, M. Schoberer, C. Stellbrink, M. Voss, and B. J. Messmer Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations Ann. Thorac. Surg., May 1, 2000; 69(5): 1358 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zaman, R. A. Archbold, G. Helft, E. A. Paul, N. P. Curzen, and P. G. Mills Atrial Fibrillation After Coronary Artery Bypass Surgery : A Model for Preoperative Risk Stratification Circulation, March 28, 2000; 101(12): 1403 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gomes, J. Ip, F. Santoni-Rugiu, D. Mehta, A. Ergin, S. Lansman, E. Pe, T. Takle Newhouse, and S. Chao Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study J. Am. Coll. Cardiol., August 1, 1999; 34(2): 334 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. VanderLugt, T. Mattioni, S. Denker, D. Torchiana, T. Ahern, L. K. Wakefield, K. T. Perry, and P. R. Kowey Efficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac Surgery Circulation, July 27, 1999; 100(4): 369 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A T. Ulus, P. Gokce, E. Ozgencil, U. Yildiz, E. Ibrisim, and S F. Katircioglu Beneficial Effects of Aminophylline on Ischemia-Reperfusion in Isolated Rabbit Heart Asian Cardiovasc Thorac Ann, June 1, 1999; 7(2): 96 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C L. Birincioglu, A T. Ulus, B. Yamak, S F. Katircioglu, B. Mavitas, and O. Tasdemir Intravenous Diltiazem for Treatment of Supraventricular Tachycardia After Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, September 1, 1998; 6(3): 203 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Liebold, A. Wahba, and D. E. Birnbaum Low-Energy Cardioversion With Epicardial Wire Electrodes: New Treatment of Atrial Fibrillation After Open Heart Surgery Circulation, September 1, 1998; 98(9): 883 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. McCullough, J. D. Redle, A. G. Zaman, A. Archbold, F. Alamgir, T. J. Ulahannan, E. G. Daoud, and F. Morady Amiodarone Prophylaxis for Atrial Fibrillation after Cardiac Surgery N. Engl. J. Med., May 7, 1998; 338(19): 1383 - 1384. [Full Text] |
||||
![]() |
U. Kloter Weber, S. Osswald, P. Buser, M. Huber, K. Skarvan, P. Stulz, and M. Pfisterer Significance of Supraventricular Tachyarrhythmias After Coronary Artery Bypass Graft Surgery and Their Prevention by Low-Dose Sotalol: A Prospective Double-Blind Randomized Placebo-Controlled Study Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(3): 209 - 216. [Abstract] [PDF] |
||||
![]() |
B. N. Singh, B. Lopez, and J. S.M. Sarma Significance and Prevention of Atrial Fibrillation Occurring After Cardiac Surgery: A Time for Fundamental Change in Strategy? Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(3): 259 - 267. [PDF] |
||||
![]() |
E. G. Daoud, S. A. Strickberger, K. C. Man, R. Goyal, G. M. Deeb, S. F. Bolling, F. D. Pagani, C. Bitar, M. D. Meissner, and F. Morady Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery N. Engl. J. Med., December 18, 1997; 337(25): 1785 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Aranki, D. P. Shaw, D. H. Adams, R. J. Rizzo, G. S. Couper, M. VanderVliet, J. J. Collins, L. H. Cohn, and H. R. Burstin Predictors of Atrial Fibrillation After Coronary Artery Surgery: Current Trends and Impact on Hospital Resources Circulation, August 1, 1996; 94(3): 390 - 397. [Abstract] [Full Text] |
||||
![]() |
B. L. Cmolik, J. Ortiz, G. M. Ayers, J. H. Lee, A. S. Geha, and A. L. Waldo SUCCESSFUL ATRIAL DEFIBRILLATION WITH VERY-LOW-ENERGY SHOCKS BY MEANS OF TEMPORARY EPICARDIAL WIRE ELECTRODES J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 392 - 398. [Abstract] [Full Text] |
||||
![]() |
J. M. Kalman, M. Munawar, L. G. Howes, W. J. Louis, B. F. Buxton, G. Gutteridge, and A. M. Tonkin Atrial Fibrillation After Coronary Artery Bypass Grafting Is Associated With Sympathetic Activation Ann. Thorac. Surg., December 1, 1995; 60(6): 1709 - 1715. [Abstract] [Full Text] |
||||
![]() |
B. K. Podesser, S. Schwarzacher, W. Zwoelfer, T. M. Binder, E. Wolner, and R. Seitelberger COMPARISON OF PERIOPERATIVE MYOCARDIAL PROTECTION WITH NIFEDIPINE VERSUS NIFEDIPINE AND METOPROLOL IN PATIENTS UNDERGOING ELECTIVE CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1461 - 1469. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |